Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

CLOV

Live52w high -11.5%

Core line items from CLOV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Entity: CLOVER HEALTH INVESTMENTS, CORP. /DE·Source: SEC EDGAR companyfacts

Metric	Annual 2025 2025-12-31	Annual 2024 2024-12-31	Annual 2023 2023-12-31	Annual 2022 2022-12-31
Revenue	$1.92B	$1.37B	$1.26B	$1.10B
Operating Income	$-85.53M	$-45.75M	$-205.33M	$-286.66M
Net Income	$-85.55M	$-43.01M	$-213.36M	$-339.57M
EPS (Diluted)	$-0.17	$-0.09	$-0.44	$-0.71
Total Assets	$541.01M	$580.74M	$570.67M	$808.62M
Total Liabilities	$232.31M	$239.60M	$284.28M	$451.73M
Cash & Equivalents	$78.30M	$194.54M	$122.86M	$103.79M
Free Cash Flow OCF − CapEx	$-68.98M	$33.29M	$-145.25M	$-208.39M
Shares Outstanding	511.97M	490.02M	482.18M	476.24M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.

Core line items from CLOV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w high -11.5%

Entity: CLOVER HEALTH INVESTMENTS, CORP. /DE·Source: SEC EDGAR companyfacts

Metric	Annual 2025 2025-12-31	Annual 2024 2024-12-31	Annual 2023 2023-12-31	Annual 2022 2022-12-31
Revenue	$1.92B	$1.37B	$1.26B	$1.10B
Operating Income	$-85.53M	$-45.75M	$-205.33M	$-286.66M
Net Income	$-85.55M	$-43.01M	$-213.36M	$-339.57M
EPS (Diluted)	$-0.17	$-0.09	$-0.44	$-0.71
Total Assets	$541.01M	$580.74M	$570.67M	$808.62M
Total Liabilities	$232.31M	$239.60M	$284.28M	$451.73M
Cash & Equivalents	$78.30M	$194.54M	$122.86M	$103.79M
Free Cash Flow OCF − CapEx	$-68.98M	$33.29M	$-145.25M	$-208.39M
Shares Outstanding	511.97M	490.02M	482.18M	476.24M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.